a Division of Nephrology , Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine , Sendai , Japan .
b Department of Clinical Pharmacology and Therapeutics , Tohoku University Graduate School of Pharmaceutical Sciences , Sendai , Japan .
Clin Exp Hypertens. 2016;38(2):203-8. doi: 10.3109/10641963.2015.1081219. Epub 2016 Jan 29.
Intrarenal RAS has been suggested to be involved in the pathogenesis of hypertension. It was recently reported that urinary angiotensinogen excretion levels are associated with intrarenal RAS. However, few markers predicting intrarenal RAS have been investigated in obese young subjects. The present study evaluated the association between blood pressure and intrarenal RAS activity, inflammation and oxidative stress in obese young adults. Urinary angiotensinogen excretion and urinary monocyte chemotactic protein (MCP)-1, and urinary thiobarbituric acid reaction substance (TBARS) as markers of intrarenal RAS activity, inflammation, and oxidative stress, respectively, were determined from morning urine of 111 young male adults. Participants were divided into two groups based on the body mass index (BMI). Natural log-transformed urinary angiotensinogen excretion level was significantly associated with blood pressure, MCP-1 excretion, and TBARS excretion elevation in the obese group (BMI ≥25 kg/m(2)). Multivariable analyses showed that every 1 standard deviation increase in natural-log transformed urinary angiotensinogen and MCP-1 excretion, but not TBARS excretion level was associated with elevated blood pressure in the obese group. These results indicate that urinary angiotensinogen and MCP-1 excretion were associated with blood pressure elevation in this population of obese young adults. It suggested that inappropriate RAS activity and inflammation precedes hypertension in obese young subjects and urinary angiotensinogen could be a screening maker for hypertension in young obese subjects.
肾内肾素-血管紧张素系统(RAS)被认为与高血压的发病机制有关。最近有报道称,尿血管紧张素原排泄水平与肾内 RAS 有关。然而,在肥胖的年轻受试者中,很少有标志物被研究来预测肾内 RAS。本研究评估了肥胖年轻成年人的血压与肾内 RAS 活性、炎症和氧化应激之间的关系。分别从 111 名年轻男性成年人的晨尿中测定尿血管紧张素原排泄和尿单核细胞趋化蛋白(MCP)-1、尿硫代巴比妥酸反应物质(TBARS)作为肾内 RAS 活性、炎症和氧化应激的标志物。根据体重指数(BMI)将参与者分为两组。在肥胖组(BMI≥25kg/m2)中,自然对数转换后的尿血管紧张素原排泄水平与血压、MCP-1 排泄和 TBARS 排泄升高显著相关。多变量分析显示,在肥胖组中,每增加一个自然对数转换后的尿血管紧张素原和 MCP-1 排泄的标准差,而不是 TBARS 排泄水平与血压升高相关。这些结果表明,在肥胖的年轻成年人中,尿血管紧张素原和 MCP-1 排泄与血压升高有关。这表明在肥胖的年轻受试者中,不适当的 RAS 活性和炎症先于高血压发生,而尿血管紧张素原可能是年轻肥胖受试者高血压的筛查标志物。